Market Size of Physician Dispensed Cosmeceuticals Industry
Study Period | 2019 - 2029 |
Market Size (2024) | USD 29.24 Billion |
Market Size (2029) | USD 41.98 Billion |
CAGR (2024 - 2029) | 7.50 % |
Fastest Growing Market | Asia Pacific |
Largest Market | North America |
Market Concentration | Medium |
Major Players*Disclaimer: Major Players sorted in no particular order |
Physician Dispensed Cosmeceuticals Market Analysis
The Physician Dispensed Cosmeceuticals Market size is estimated at USD 29.24 billion in 2024, and is expected to reach USD 41.98 billion by 2029, growing at a CAGR of 7.5% during the forecast period (2024-2029).
Factors such as increasing beauty consciousness and growing awareness of physician-dispensed cosmeceuticals are contributing to the overall growth of the market studied. The market is experiencing an accelerating demand for anti-aging products like anti-wrinkle creams, face creams, serums, and eye creams. In addition, pollution and hard water conditions are boosting the need for cosmeceuticals.
The aging population is more prone to wrinkles and frown lines on their skin and forehead, and the target population is actively taking skincare procedures and therapies to manage and maintain their appearance. For instance, a report published by the Journal of Clinical and Diagnostic Research in September 2023 stated that the majority of patients aged 60-69 reported wrinkling of skin as the most common physiological skin finding, followed by dry skin. Hence, the increasing geriatric population is expected to propel the demand for physician-dispensed cosmeceuticals to treat such aesthetic issues better, thus driving the market's growth.
Furthermore, the rise in the availability of advanced products, increasing awareness about enhancing aesthetic appeal, and the rise in disposable income levels and spending on personal care products are the significant factors driving the market's growth. In addition, the growing social media influence worldwide has facilitated the adoption of cosmeceuticals, which is expected to benefit market growth over the study period. For instance, as per one of the articles published by the American Society of Plastic Surgeons in September 2023, the digital era of social media positively impacted the cosmetic industry. This highlights the increased access to information about celebrities undergoing cosmetic procedures and products. The digital era is contributing to the increased usage of cosmeceuticals, thereby boosting market growth.
Therefore, the market studied is anticipated to witness growth over the analysis period owing to factors such as the growing aging population and social media's influence on aesthetic appearance. However, the high cost of the products and the lack of trained and skilled professionals are predicted to hinder the market's growth over the forecast period.
Physician Dispensed Cosmeceuticals Industry Segmentation
As per the scope of the report, physician-dispensed cosmeceuticals refer to products that are only accessible through a medically directed business and are geared toward creating actual biological actions on the skin below the stratum corneum. Many physicians whose practices or specialties involve skin health choose to dispense these cosmeceuticals or have them specially compounded to offer heightened results to their patients and to enhance their results with other treatments.
The physician-dispensed cosmeceuticals market is segmented by type and geography. By type, the market is segmented into skin care, eye care, hair care, and other types. The skin care segment includes anti-aging, sunscreens, and other skin care products. The eye care segment includes eye drops and other eye care products. The hair care segment includes hair repair, anti-dandruff, and other hair care products. By geography, the market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and South America. The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers market sizes and forecasts in terms of value (USD) for all the abovementioned segments.
By Type | |||||
| |||||
| |||||
| |||||
Other Types |
Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Physician Dispensed Cosmeceuticals Market Size Summary
The Physician Dispensed Cosmeceuticals Market is poised for significant growth, driven by increasing beauty consciousness and awareness of these specialized products. The market is experiencing a surge in demand for anti-aging solutions, such as creams and serums, fueled by the aging population and the desire to maintain a youthful appearance. The COVID-19 pandemic has also played a role in shaping consumer behavior, with heightened focus on skincare due to prolonged mask-wearing and increased awareness of skin health. Despite challenges like high product costs and a shortage of trained professionals, the market is expected to expand as consumers seek effective and personalized skincare solutions that penetrate deeper than over-the-counter options.
North America is anticipated to lead the market, supported by the availability of advanced products and high consumer awareness. Regulatory frameworks, such as those by the FDA, ensure the safety and efficacy of cosmeceuticals, further boosting consumer confidence. The region's market growth is also bolstered by numerous players in the aesthetic industry, offering innovative products. The competitive landscape is marked by significant investments in research and development, with key players like Allergan and Merz Pharma driving product innovation. As the demand for physician-dispensed cosmeceuticals continues to rise, the market is set to witness robust growth over the forecast period.
Physician Dispensed Cosmeceuticals Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Increasing Beauty Consciousness
-
1.2.2 Growing Awareness About Physician Dispensed Cosmeceuticals
-
-
1.3 Market Restraints
-
1.3.1 High Cost of the Products
-
1.3.2 Lack of Trained and Skilled Professionals
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD)
-
2.1 By Type
-
2.1.1 Skin Care
-
2.1.1.1 Anti-Ageing
-
2.1.1.2 Sunscreens
-
2.1.1.3 Other Skin Care Products
-
-
2.1.2 Eye Care
-
2.1.2.1 Eye Drops
-
2.1.2.2 Other Eye Care Products
-
-
2.1.3 Hair Care
-
2.1.3.1 Hair Repair
-
2.1.3.2 Anti-dandruff
-
2.1.3.3 Other Hair Care Products
-
-
2.1.4 Other Types
-
-
2.2 Geography
-
2.2.1 North America
-
2.2.1.1 United States
-
2.2.1.2 Canada
-
2.2.1.3 Mexico
-
-
2.2.2 Europe
-
2.2.2.1 Germany
-
2.2.2.2 United Kingdom
-
2.2.2.3 France
-
2.2.2.4 Italy
-
2.2.2.5 Spain
-
2.2.2.6 Rest of Europe
-
-
2.2.3 Asia-Pacific
-
2.2.3.1 China
-
2.2.3.2 Japan
-
2.2.3.3 India
-
2.2.3.4 Australia
-
2.2.3.5 South Korea
-
2.2.3.6 Rest of Asia-Pacific
-
-
2.2.4 Middle East and Africa
-
2.2.4.1 GCC
-
2.2.4.2 South Africa
-
2.2.4.3 Rest of Middle East and Africa
-
-
2.2.5 South America
-
2.2.5.1 Brazil
-
2.2.5.2 Argentina
-
2.2.5.3 Rest of South America
-
-
-
Physician Dispensed Cosmeceuticals Market Size FAQs
How big is the Physician Dispensed Cosmeceuticals Market?
The Physician Dispensed Cosmeceuticals Market size is expected to reach USD 29.24 billion in 2024 and grow at a CAGR of 7.5% to reach USD 41.98 billion by 2029.
What is the current Physician Dispensed Cosmeceuticals Market size?
In 2024, the Physician Dispensed Cosmeceuticals Market size is expected to reach USD 29.24 billion.